Moderna's announced plans to manufacture COVID-19 vaccines in Kenya

preview_player
Показать описание
Moderna's announced plans to manufacture COVID-19 vaccines in Kenya. The pharmaceutical company holds much of the key intellectual property relating to mRNA vaccines, which are preferred in developed nations due to their better efficacy rates. University of Pretoria technology management Professor, David Richard Wal-wyn weigh in.

Tune into Newzroom Afrika, DSTV channel 405 for more details.
Рекомендации по теме